US2011288136A1PendingUtilityA1
Flavivirus inhibition by sultams and related compounds
Est. expiryMar 16, 2026(expired)· nominal 20-yr term from priority
Inventors:Eric Barklis
G06T 15/08G06T 2207/30016G06T 2207/10092C07D 285/01G06T 7/181G06T 2207/20156A61P 31/12G06T 7/12G01R 33/56341A61P 31/14G01R 33/5608G06V 10/248G06V 10/457G06V 2201/03
25
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are compounds, compositions and methods for treating or ameliorating flavivirus infections. This is particularly important because the present disclosure provides methods for treating flavivirus infections for which there is no effective vaccine.
Claims
exact text as granted — not AI-modified1 . A method for inhibiting flavivirus replication, comprising contacting a virus with a compound of the formula
wherein X is —S—, —S(O)—, —SO 2 —, —CH 2 —, —N(R 3 )—, —C(O)— or —O—,
Y is —S—, —N(R 4 )—, —C(R 5 )(R 6 )—, or —O—;
Z is S, N or O;
J is N or C(R 7 );
A is —N(R 8 )(R 9 ), —OR 8 or —CR 9 R 10 R 11 ;
G is N or CH;
R 1 is selected from H, lower alkyl, aralkyl, aryl, halogen and halo alkyl;
R 2 is selected from lower alkyl, aralkyl, aryl;
R 3 , R 4 , R 5 , R 6 and R 7 independently are selected from H, lower alkyl, heteroalkyl, heterocyclyl, aralkyl and aryl
R 8 and R 9 independently are selected from lower alkyl, heteroalkyl, heterocyclyl, aralkyl and aryl; and
R 10 and R 11 independently are selected from H, lower alkyl, heteroalkyl, heterocyclyl, aralkyl and aryl.
2 . The method of claim 1 , wherein the compound has the formula
wherein X is —S—, —S(O)—, —SO 2 —, —N— or —O—;
Y is —S—, —N— or —O—;
Z is S, N or O;
A is —N(R 8 )(R 9 ) or —OR 8 ;
R 1 is selected from H, lower alkyl, aralkyl, aryl, halogen and halo alkyl;
R 2 is selected from lower alkyl, aralkyl, aryl; and
R 8 and R 9 independently are selected from lower alkyl, heteroalkyl, heterocyclyl, aralkyl and aryl.
3 . The method of claim 1 , wherein X is —S—, —S(O)— or —SO 2 —.
4 . The method of claim 1 , wherein Y is —S—.
5 . The method of claim 1 , wherein Z is S.
6 . The method of claim 1 , wherein the compound has the formula
wherein X is —S—, —S(O)—, —SO 2 —, —N— or —O—;
Y is —S—, —N— or —O—;
Z is S, N or O;
R 1 is selected from H, lower alkyl, aralkyl, aryl, halogen and halo alkyl;
R 2 is selected from lower alkyl, aralkyl, aryl; and
R 8 and R 9 independently are selected from lower alkyl, heteroalkyl, heterocyclyl, aralkyl and aryl.
7 . The method of claim 1 , wherein the compound has the formula
wherein R 1 ; R 2 ; R 8 and R 9 are as set forth above.
8 . The method of claim 6 , wherein R 1 is selected from H, methyl, ethyl, propyl, isopropyl, benzyl and phenyl.
9 . The method of claim 6 , wherein R 2 is selected from lower alkyl, lower haloalkyl, optionally substituted phenyl, optionally substituted benzyl and haloalkyl.
10 . The method of claim 7 , wherein R 2 represents
wherein R 6 is independently selected for each n from aryl, halogen, haloalkyl, lower alkyl, alkoxy, hydroxy, and n is an integer of 0-5.
11 . The method of claim 7 , wherein R 8 and R 9 are independently selected from lower alkyl, aryl and aralkyl.
12 . The method of claim 7 , wherein R 8 and R 9 are independently selected from methyl, ethyl, isopropyl and t-butyl.
13 . The method of claim 6 , wherein R 8 and R 9 are the same.
14 . The method of claim 10 , wherein the compound has the formula
wherein X, Y, Z, R 1 and n are as set forth above;
R 13 and R 14 , are for each m and p, independently selected from lower alkyl and halo; and
m and p independently are from 0-5.
15 . The method of claim 10 , wherein the compound has the formula
wherein R 12 , R 13 and R 14 , are for each m and p, independently selected from lower alkyl, halogen and haloalkyl; and
m and p independently are from 0-5.
16 . The method of claim 15 , wherein n=m=p=0.
17 . The method of claim 1 , wherein the compound has the formula
18 . The method of claim 1 , wherein the compound has the formula
19 . The method of claim 1 , wherein the compound is selected from the group consisting of N′-(1,1-dioxido-2-phenyl-1,4,2-dithiazolidin-3-ylidene)-N,N-diphenylthiourea; (2,5-dimethyl-1,1-dioxido-1,4,2-dithiazolidin-3-ylidene)bis(1-methylethyl)thiourea; [1,1-dioxido-2-(phenylmethyl)-1,4,2-dithiazolidin-3-ylidene]bis(1-methylethyl)-thiourea; (1,1-dioxido-2-phenyl-1,4,2-dithiazolidin-3-ylidene)-bis(phenylmethyl)-thiourea; and combinations thereof.
20 . A method of treating or ameliorating a viral infection in a subject, comprising
identifying a subject either at risk of infection with or infected with a virus; and administering to the subject an effective amount of a compound of the formula
wherein X is —S—, —S(O)—, —SO 2 —, —N— or —O—;
Y is —S—, —N— or —O—;
Z is S, N or O;
A is —N(R 3 )(R 4 ) or —OR 5 ;
R 1 is selected from H, lower alkyl, aralkyl, aryl, halogen and halo alkyl;
R 2 is selected from lower alkyl, aralkyl, aryl; and
R 3 , R 4 and R 5 independently are selected from lower alkyl, heteroalkyl, heterocyclyl, aralkyl and aryl.Join the waitlist — get patent alerts
Track US2011288136A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.